Abstract
"The global pharmaceutical market grew to US$712 billion in 2007, growing at a
compound annual growth rate (CAGR) of 10.0% between 1999 and 2007.
Year-on-year growth in the global pharmaceutical market increased to 10.7% in
2007, largely as a result of strong sales growth for new innovative products
and high market growth in emerging pharmaceutical markets such as China."
2008 updated version of this best-selling report!
Pharmaceutical Market Trends, 2008 - 2012: Key market forecasts & growth
opportunities presents a detailed trend analysis of the global pharmaceutical
market as at the end of 2006 and forecasts until 2012. The 142 page report
presents a series of market forecasts and growth opportunities in order to
help inform pharmaceutical decision-making, particularly in the areas of
corporate planning, portfolio management and market forecasting.
The data and analysis contained within the report are comprehensive,
consistent and up-to-date in order to provide a single-point reference for
understanding key pharmaceutical market trends in 2008.
KEY FINDINGS INCLUDE
- The global pharmaceutical market is forecast to grow to US$929 billion in
2012, an equivalent compound annual growth rate (CAGR) of 5.5% over the next
five years.
- In 2007 the leading therapy areas by sales were CNS with 16.5% share and
cardiovascular with 15.4%.
- Four of the top 10 products in 2007 are forecast to increase sales over
the next five years.
- The US retail pharmaceutical market grew to US$206 billion but growth
rates fell due to loss of patent protection on some blockbusters
- France, Germany and the UK together accounted for almost 50% of all
European pharmaceutical sales in 2007.
- TThe top 100 blockbuster drugs generated sales of US$252.5 billion,
accounting for 35.5% of the total pharmaceutical market.
- The leading blockbuster by increased sales revenues in 2007 was the blood
agent product Plavix (clopidogrel bisulfate), marketed by Sanofi-Aventis and
Bristol-Myers Squibb.
- There were a total of 61 companies generating pharmaceutical sales in
excess of US$1 billion in 2007
KEY FEATURES OF THE REPORT
- Comprehensive market trends for key countries, regions , therapy areas,
products and companies.
- Country profiles for leading pharma markets with market segment trends and
5 year forecasts.
- Therapy area profiles for leading therapeutic classes and key products and
2012 sales forecasts.
- Detailed profiles of 10 leading pharmaceutical products in 2008, including
five year future sales forecasts.
- Detailed profiles of 10 leading pharmaceutical companies in 2008,
including 2012 sales forecasts.(AstraZeneca, Eli Lilly, GlaxoSmithKline,
Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth)
USE THIS REPORT TO:
- 1. Quickly gain an overview into the global pharmaceutical market and its
major companies and products.
- 2. Identify key areas of pharmaceutical market growth and key
opportunities for delivering successful sales growth over the next five years.
- 3. Support internal planning and decision-making with an external
perspective founded on detailed analysis and transparent market forecasts.
REPORT COVERAGE
The report methodology provides a detailed but transparent analysis of key
pharmaceutical market trends, including key markets, therapy areas, products
and companies. Historical trends are formed over a three-year time horizon and
future forecasts are made using a five-year future time period. Thus, the data
and analysis relate to the nine-year time horizon from 2005 to 2012.
All data used in outlining historical trends is clearly sourced within the
report and any data limitations or additional assumptions are explicitly
detailed within the text of the report. Future market forecasts are projected
based on both historical trends and future expectations over market conditions
and events. The assumptions used to form the basis of key market forecasts are
outlined in detail within the text of the report.
View Cart
